TI
CDLX icon

Trexquant Investment’s Cardlytics CDLX Stock Holding History

Trexquant Investment’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,046
Closed -$338K – 1459
2023
Q3 		$338K Sell
2,046
-5,555
-73% -$722K 0.01% 1185
2023
Q2 		$480K Buy
+7,601
New +$460K 0.01% 1021
2021
Q3 		– Sell
-220
Closed -$279K – 1165
2021
Q2 		$279K Sell
220
-53
-19% -$59.8K 0.02% 745
2021
Q1 		$299K Buy
+273
New +$360K 0.03% 751
2019
Q1 		– Sell
-1,601
Closed -$173K – 1017
2018
Q4 		$173K Buy
+1,601
New +$270K 0.01% 941

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return

Trexquant Investment's CDLX Position: Q4 2023 in Review

Trexquant Investment sold out of Cardlytics (CDLX) in Q4 2023, closing a stake of 2,046 shares — an estimated $338K sold.

Trexquant Investment first reported a position in CDLX in Q4 2018 and held it in 5 quarters. The position peaked at $480K in Q2 2023. 124 funds tracked by Wall St. Rank hold CDLX as of Q4 2023.

  • Trexquant Investment reported no remaining Cardlytics position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 2,046 Cardlytics shares in Q4 2023, an estimated $338K.
  • Trexquant Investment first reported a position in Cardlytics in Q4 2018 and held it in 5 quarters.
  • Trexquant Investment's Cardlytics position peaked at $480K in Q2 2023.
  • 124 funds tracked by Wall St. Rank held Cardlytics as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.